{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Changes in California could see significant impact on the price of prescription drugs",
    "url": "https://www.lexblog.com/2019/06/03/california-prescription-drug-purchasing-initiative-raises-numerous-questions/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-JM409KEC",
        "url": "https://www.lexblog.com/lib/JM409KEC/"
    },
    "datePublished": "2019-06-03T17:11:01-04:00",
    "dateModified": "2019-06-07T02:31:20-04:00",
    "author": {
        "@type": "Person",
        "name": "Robert Hill, Joseph W. Metro, Edward Schwartz, Paul W. Pitts, Karl Herrmann"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Antitrust and Competition Report",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "http://antitrustandcompetitionupdate.reedsmithblogs.com/?p=1900",
    "sourceStability": "may-move"
}